Interview Questions for Samir Hanash
Interview with Samir Hanash, MD Anderson Cancer Center Responses to interview questions from Tal Behar, Precision Medicine World Conference Samir Hanash, The University of Texas MD Anderson Cancer Center | PMWC 2027 Silicon Valley, Track 3, Day 1, Session 2: The End of One Size Fits All Interview Personalized Cancer Screening Proteomics & AI View […]
Interview Questions for Jay Bradner
Interview with Jay Bradner, M.D., Amgen Responses to interview questions from Tal Behar, Precision Medicine World Conference James “Jay” Bradner, M.D., Executive Vice President, Research and Development, Artificial Intelligence and Data, Amgen Interview Drug Discovery & Chemical Biology AI & Data in R&D View the Developing PMWC 2027 Program 1 Reaching the Undruggable Proteome: Molecular […]
Interview Questions for Nickolas Papadopoulos
Interview with Nickolas Papadopoulos, Ph.D., Johns Hopkins University Responses to interview questions from Tal Behar, Precision Medicine World Conference Nickolas Papadopoulos, Ph.D., Professor of Oncology and Pathology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Director of Translational Genetics, Ludwig Center at Johns Hopkins University Interview Early Cancer Detection Multi-Cancer Screening View the Developing PMWC 2027 […]
Interview Questions for Sarah-Jane Dawson
<!doctype html> Interview with Professor Sarah-Jane Dawson, University of Melbourne Responses to interview questions from Tal Behar, Precision Medicine World Conference Professor Sarah-Jane Dawson, Peter MacCallum Cancer Centre / University of Melbourne PMWC 2027 Track 3, Day 2 Luminary Honoree Talk: Liquid Biopsy for Precision Medicine: Going Beyond the Cancer Genome Interview Liquid Biopsy […]
Interview Questions for Rebecca Fitzgerald
Interview with Professor Rebecca Fitzgerald, University of Cambridge Interview with Professor Rebecca Fitzgerald, University of Cambridge Responses to interview questions from Tal Behar, Precision Medicine World Conference Professor Rebecca Fitzgerald, University of Cambridge PMWC 2027 Track 3, Day 1 Luminary Honoree Topic: Early cancer detection, Capsule Sponge implementation, and moving from screening to interception Interview […]
Interview Questions for Tal Zaks
Interview with Tal Zaks, Partner, OrbiMed Advisors LLC Interview with Tal Zaks, Partner, OrbiMed Advisors LLC Responses to interview questions from Tal Behar, Precision Medicine World Conference Tal Zaks, Partner, OrbiMed Advisors LLC Topic: Personalized mRNA cancer vaccines, ROI realities, and what it takes to win in oncology beyond the COVID playbook Interview mRNA Oncology […]
Interview Questions for Ed Kim, City of Hope
Interview with Track Chair: Edward S. Kim, MD, City of Hope Interview with PMWC 2026 Track Chair: Edward S. Kim, MD, City of Hope Responses to interview questions from Tal Behar, Precision Medicine World Conference Edward S. Kim, MD, Vice Physician-in-Chief, City of Hope National Medical Center; System Director, Clinical Trials, City of Hope Track […]
Interview Questions for Dennis J. Slamon, UCLA
Interview with Pioneer Honoree: Dennis J. Slamon, UCLA Interview with Pioneer Honoree: Dennis J. Slamon, UCLA Responses to interview questions from Tal Behar, Precision Medicine World Conference Keynote in Track 3 Day 2: Molecular Diversity of Human Malignacies: Diagnostic and Therapeutic Implications PMWC 2026 Pioneer Honoree Track 3 Day 2 Keynote View the Full PMWC […]
Interview Questions for Dmitry Gabrilovich, AstraZeneca
Dmitry Gabrilovich (AstraZeneca) Responses to interview questions from Tal Behar, Precision Medicine World Conference 1. Trial Design Question: In myeloid-targeting combination trials in solid tumors, what’s the most common trial-design mistake you see (patient selection, timing, endpoints, assays), and what one change would you make first to avoid false “no-signal” outcomes? Answer: The challenges with […]
Interview Questions for Suzanne Topalian, Johns Hopkins
Suzanne Topalian’s (Johns Hopkins) responses to interview questions from Tal Behar, Precision World Medicine Conference 1) The single biomarker you’d actually gate treatment on in 2026 (setting + cutoff) — and why. In my opinion, the single most reliable biomarker for anti-PD-1-based therapy, among three that are currently FDA-approved and many that are still in […]
